Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women
- PMID: 20043203
- PMCID: PMC3382111
- DOI: 10.1007/s10552-009-9473-1
Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women
Abstract
Introduction: This study examines factors associated with timely follow-up after Pap test in a program providing cervical cancer detection services to medically underserved California women.
Methods: Data between 01 January 1992 and 30 June 2007 were analyzed. Cox proportional hazard regression was used to identify subgroups of women with delayed time to diagnosis or treatment scheduling. The probability of being scheduled for final diagnosis and treatment was assessed using logistic regression analysis. Demographic and clinical characteristics of the women lost to follow up were examined.
Results: Time from screening to final diagnosis scheduling differed according to age group, race/ethnicity, and Pap test result. Race/ethnicity and age were associated with whether treatment was scheduled or not. While loss to follow up among those scheduled for final diagnosis was associated with certain patients' characteristics, no such association was found among those who were scheduled for treatment.
Conclusions: Patient's demographic characteristics determine the odds of being scheduled for final diagnosis and treatment as well as timeliness of follow-up from screening to final diagnosis. Findings suggest that the dual goal of reducing health disparities and cost-effective detection and treatment of precancerous disease to prevent cervical cancers cannot be achieved without consideration of racial/ethnic differences and needs.
Similar articles
-
Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.Cancer Detect Prev. 2009;32(5-6):372-9. doi: 10.1016/j.cdp.2009.02.001. Epub 2009 Mar 4. Cancer Detect Prev. 2009. PMID: 19264426
-
Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.Diagn Cytopathol. 2009 Feb;37(2):103-10. doi: 10.1002/dc.20965. Diagn Cytopathol. 2009. PMID: 19021201
-
An inpatient cervical cancer screening program to reach underserved women.J Obstet Gynecol Neonatal Nurs. 2000 Sep-Oct;29(5):465-73. doi: 10.1111/j.1552-6909.2000.tb02767.x. J Obstet Gynecol Neonatal Nurs. 2000. PMID: 11012125
-
Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S205-10. doi: 10.1016/S0020-7292(06)60035-0. Int J Gynaecol Obstet. 2006. PMID: 17161159 Review. No abstract available.
-
Evidence-based, alternative cervical cancer screening approaches in low-resource settings.Int Perspect Sex Reprod Health. 2009 Sep;35(3):147-54. doi: 10.1363/ifpp.35.147.09. Int Perspect Sex Reprod Health. 2009. PMID: 19805020 Review. No abstract available.
Cited by
-
Multiple barriers delay care among women with abnormal cancer screening despite patient navigation.J Womens Health (Larchmt). 2015 Jan;24(1):30-6. doi: 10.1089/jwh.2014.4869. Epub 2014 Dec 16. J Womens Health (Larchmt). 2015. PMID: 25513858 Free PMC article.
-
Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.Contemp Clin Trials. 2018 Jan;64:77-87. doi: 10.1016/j.cct.2017.11.004. Epub 2017 Nov 4. Contemp Clin Trials. 2018. PMID: 29113956 Free PMC article. Clinical Trial.
-
Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program.J Womens Health (Larchmt). 2012 Jul;21(7):776-82. doi: 10.1089/jwh.2011.3224. Epub 2012 Apr 16. J Womens Health (Larchmt). 2012. PMID: 22506920 Free PMC article.
-
Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.Can Fam Physician. 2012 Jan;58(1):e22-31. Can Fam Physician. 2012. PMID: 22267636 Free PMC article.
-
Determinants of Abnormal Cervical Cancer Screening Follow-Up And Invasive Cervical Cancer Among Uninsured and Underinsured Women in New Jersey.J Health Care Poor Underserved. 2019;30(2):680-701. doi: 10.1353/hpu.2019.0050. J Health Care Poor Underserved. 2019. PMID: 31130545 Free PMC article.
References
-
- American Cancer Society. What are the key statistics about cervical cancer? (last revised: 05/13/2009. http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_are_the_key_st... Checked on August 07, 2009.
-
- Christopherson WM, Lundin FE, Mendez WM, Parker JE. Cervical cancer control: a study of morbidity and trends over a twenty-one year period. Cancer. 1976;38:1357–1366. - PubMed
-
- Clarke EA, Anderson TW. Does screening by “Pap” test help prevent cervical cancer? a case-control study. Lancet. 1979;2:1–4. - PubMed
-
- Boyes DA. The value of a Pap test program and suggestions for its implementation. Cancer. 1981;48(suppl):613–621. - PubMed
-
- Wright TC, Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2001;287:2120–2129. - PubMed